Skip to main content
. 2020 Aug 15;25(16):3723. doi: 10.3390/molecules25163723

Figure 6.

Figure 6

Docking protocol validation, 4-dibromo-6-{[(2-nitrobenzene-1-carbonyl)amino] methylphenyl benzoate redocked with LasR ligand-binding domain, 6D6A. Conformation of the docked molecule was found to be similar to the conformation of the inhibitor reported with 6D6A.